An official website of the United States government
Home
Name
Zalutumumab
Alternate Names
HuMax-EGFr
Abbreviations
None
Category
Chemotherapy
Subcategory
Cytostatic agent--anti-EGFR
NSC Number
None
Primary Site
H&N
NSCLC
Histology
None
Remarks
The company that makes this agent have decided not to continue to develop the drug and are looking for a partner to continue as th the expenses for the drug and trials is overwhelming. This drug has not received FDA approval and is not approved for use in Eurpoe.
Phase II H&N, NSCLC 2007
Human monoclonal anti-EGFR. Genmab
Phase II H&N, NSCLC 2007
Human monoclonal anti-EGFR. Genmab
Coding
This drug should be coded
